{"prompt": "['Protocol Identifying Number: PS-001', 'Protocol Version: 1.0', 'Protocol Date: 10 Sep 2017', '9.5 Conditions for Modifying the Protocol', 'Protocol modifications will be prepared, reviewed, and approved by the Investigators. All protocol', 'modifications must be submitted to the IRB for information and approval in accordance with local', 'requirements, and to regulatory agencies if required. Approval must be obtained before any changes', 'can be implemented, except for changes necessary to eliminate an immediate hazard to study', 'subjects, or when the change involves only logistical or administrative aspects of the trial.', '9.6 Insurance', 'All patients participating in the study will have insurance coverage by the National Health Fund.', '10. Bibliographic References', '1.', 'Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D,', 'Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No.', '11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from:', 'http://globocan.iarc.fr, accessed on 10 May 2017.', '2.', 'Cancer Facts and Figures 2016. American Cancer Society, 2016. Available from:', 'ittps://old.cancer.org/acs/groups/content/@research/documents/document/acspc-', '047079.pdf, accessed on 2 Apr 2017.', '3.', 'Surveillance Epidemiology and End Results. SEER Stat Fact Sheets. National Cancer Institute.', 'Available from: http://seer.cancer.gov/statfacts/html/kidrp.html, accessed on 10 May 2017.', '4.', 'Lopez-Beltran A, Carrasco JC, Cheng L, et al. 2009 update on the classification of renal epithelial', 'tumors in adults. Int J Urol. 2009; 16:432-43.', '5.', 'Collins ET. Intra-ocular growths (two cases, brother and sister, with peculiar vascular new', 'growth, prob-ably retinal, affecting both eyes). Trans Ophthalmol Soc UK. 1894; 14:141-9.', '6. von Hippel E. Ueber eine sehr seltene Erkrankung der Nethaut. Graefe Arch Ophthalmol. 1904;', '59:83-106.', '7. Lindau A. Zur Frage der Angiomatosis Retinae und Ihrer Hirncomplikation. Acta Opthalmol. 1927;', '4:193-226.', '8. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor', 'gene. Science. 1993; 260:1317-20.', '9.', 'Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scientific review.', 'Eur J Hum Genet. 2011; 19:617-23.', '10. Lee S, Neumann M, Stearman R, et al. Transcription-dependent nuclear-cytoplasmic trafficking is', 'required for the function of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol.', '1999; 19:1486-97.', '11. Oya M, Takayanagi A, Horiguchi A, et al. Increased nuclear factor-kappa B activation is related to', 'the tumor development of renal cell carcinoma. Carcinogenesis. 2003; 24:377-84.', '12.', 'Gao C, Cao W, Bao L, et al. Autophagy negatively regulates Wnt signalling by promoting', 'Dishevelled degradation. Nat Cell Biol. 2010; 12:781-90.', '13. Pfaffenroth EC, Linehan M. Genetic basis for kidney cancer: Opportunity for disease-specific', 'approaches to therapy. Expert Opin Biol Ther. 2008; 8:779-90.', '14. Bader HL, Hsu T. Systemic VHL gene functions and the VHL disease. FEBS Lett. 2012; 586:1562-9.', 'Page 42 of 60']['Protocol Identifying Number: PS-001', 'Protocol Version: 1.0', 'Protocol Date: 10 Sep 2017', '15. Nickerson ML, Jaeger E, Shi Y, et al. Improved identification of von Hippel-Lindau gene', 'alterations in clear cell renal tumors. Clin Cancer Res. 2008; 14 (15):4726-34.', '16. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution', 'revealed by multiregion sequencing. N Engl J Med. 2012; 366(10):883-92.', '17. Daly CJ, McGrath JC. Previously unsuspected widespread cellular and tissue distribution of', 'betaadrenoceptors and its relevance to drug action. Trends Pharmacol Sci. 2011; 32:219-26.', '18. Montminy M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem. 1997; 66:807-22.', '19. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, et al. Genome-wide analysis of', 'CAMP-response element binding protein occupancy, phosphorylation, and target gene activation', 'in human tissues. Proc Natl Acad Sci U S A. 2005; 102:4459-64.', '20. de Rooij J, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rap1 guanine-nucleotide-exchange factor', 'directly activated by cyclic AMP. Nature. 1998; 396:474-7.', '21. Schuller HM, Al-Wadei HA. Neurotransmitter receptors as central regulators of pancreatic', 'cancer. Future Oncol 2010; 6:221-8.', '22. Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a', 'mouse model of ovarian carcinoma. Nat Med 2006; 12:939-44.', '23. Al-Wadei HA, Ullah MF, Al-Wadei MH. Intercepting neoplastic progression in lung malignancies', 'via the beta adrenergic (beta-AR) pathway: implications for anti-cancer drug targets. Pharmacol', 'Res 2012; 66:33-40.', '24. Lang K, Lt Drell T, Lindecke A, et al. Induction of a metastatogenic tumor cell type by', 'neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 2004;', '112:231-8.', '25. Park SY, Kang JH, Jeong KJ, et al. Norepinephrine induces VEGF expression and angiogenesis by a', 'hypoxia-inducible factor-1alpha protein-dependent mechanism. Int J Cancer 2011; 128:2306-16.', '26. Sood AK, Armaiz-Pena GN, et al. Adrenergic modulation of focal adhesion kinase protects human', 'ovarian cancer cells from anoikis. J Clin Invest. 2010; 120: 1515-23.', '27. Sastry KS, Karpova Y, Prokopovich S, et al. Epinephrine protects cancer cells from apoptosis via', 'activation of CAMP-dependent protein kinase and BAD phosphorylation. J Biol Chem. 2007;', '282:14094-100.', '28. Armaiz-Pena GN, Allen JK, Cruz A, et al. Src activation by beta-adrenoreceptors is a key switch', 'for tumour metastasis. Nat Commun 2013; 4:1403.', '29. Shahzad MM, Arevalo JM, Armaiz-Pena GN, et al. Stress effects on FosB- and interleukin-8 (IL8)-', 'driven ovarian cancer growth and metastasis. J Biol Chem 2010; 285:35462-70.', '30. Sloan EK, Priceman SJ, Cox BF, et al. The sympathetic nervous system induces a metastatic', 'switch in primary breast cancer. Cancer Res 2010; 70:7042-52.', '31. Hara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, et al. A stress response', 'pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature.', '2011; 477:349-53.', '32. Inbar S, Neeman E, Avraham R, Benish M, Rosenne E, Ben-Eliyahu S. Do stress responses', 'promote leukemia progression? An animal study suggesting a role for epinephrine and', 'prostaglandin-E2 through reduced NK activity. PLoS One. 2011; 6:e19246.', '33. Collado-Hidalgo A, Sung C, Cole S. Adrenergic inhibition of innate anti-viral response: PKA', 'blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1', 'replication. Brain Behav Immun. 2006; 20:552-63. Epub 2006 Feb 2028.', 'Page 43 of 60']\n\n###\n\n", "completion": "END"}